Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Clinical trial NCT06935409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06935409
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2026-08-31
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.